Description
Femara 2.5mg Tablets is a 2.5mg letrozole tablet, a third-generation aromatase inhibitor used for postmenopausal hormone receptor-positive breast cancer. It suppresses estrogen synthesis by blocking peripheral aromatization. Manufactured by Novartis.
Reviews
There are no reviews yet.